2022 Vol.40, N°9 - Table of contents
September 2022
One year in review
CER16095
2022,40,9
Pg. 1611-1619
Free to view
Psoriatic arthritis: one year in review 2022
C. Cigolini, F. Fattorini, S. Gentileschi, R. Terenzi, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/x3sfxe
C. Cigolini, F. Fattorini, S. Gentileschi, R. Terenzi, L. Carli
DOI: https://doi.org/10.55563/clinexprheumatol/x3sfxe
Full Papers
CER14411
2022,40,9
Pg. 1620-1628
Free to view
The JAK inhibitor baricitinib inhibits oncostatin M induction of proinflammatory mediators in ex-vivo synovial derived cells
S. Weston, J.L. Macdonald, L.M. Williams, E. Roussou, N.V. Kang, S. Kiriakidis, P.C. Taylor
DOI: https://doi.org/10.55563/clinexprheumatol/cfsajk
S. Weston, J.L. Macdonald, L.M. Williams, E. Roussou, N.V. Kang, S. Kiriakidis, P.C. Taylor
DOI: https://doi.org/10.55563/clinexprheumatol/cfsajk
CER14827
2022,40,9
Pg. 1629-1635
Clinical characteristics of IgG4-related respiratory disease patients: a large Chinese cohort study
Z. Wang, J. Li, X. Zhang, Q. Zeng, Z. Wang, F. Yang, W. Bian, J. Fu, Y. Zhang, X. Chi, Y. Wu, Q. Shi, Z. An, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/6pnin0
Z. Wang, J. Li, X. Zhang, Q. Zeng, Z. Wang, F. Yang, W. Bian, J. Fu, Y. Zhang, X. Chi, Y. Wu, Q. Shi, Z. An, Y. Liu
DOI: https://doi.org/10.55563/clinexprheumatol/6pnin0
CER14817
2022,40,9
Pg. 1636-1641
Free to view
Autoantibodies targeting LINE-1-encoded ORF1p are associated with systemic lupus erythematosus diagnosis but not disease activity
B. Antiochos, M. Paz, J. Li, D.W. Goldman, M. Petri, E. Darrah, K. Cashman, I. Sanz, K.H. Burns, D. Ardeljan, F. Andrade, A. Rosen
DOI: https://doi.org/10.55563/clinexprheumatol/bfz387
B. Antiochos, M. Paz, J. Li, D.W. Goldman, M. Petri, E. Darrah, K. Cashman, I. Sanz, K.H. Burns, D. Ardeljan, F. Andrade, A. Rosen
DOI: https://doi.org/10.55563/clinexprheumatol/bfz387
CER14904
2022,40,9
Pg. 1642-1649
Idiopathic retroperitoneal fibrosis: clinical features, treatment modalities, relapse rate in Greek patients and a review of the literature
E. Zampeli, A.I. Venetsanopoulou, S. Christaki, O.D. Argyropoulou, K.A. Boki, M.N. Manoussakis, F.N. Skopouli, A.G. Tzioufas, H.M. Moutsopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/umzfau
E. Zampeli, A.I. Venetsanopoulou, S. Christaki, O.D. Argyropoulou, K.A. Boki, M.N. Manoussakis, F.N. Skopouli, A.G. Tzioufas, H.M. Moutsopoulos
DOI: https://doi.org/10.55563/clinexprheumatol/umzfau
CER15012
2022,40,9
Pg. 1650-1656
Clinical characteristics and outcomes of lupus myocarditis: a retrospective case control study in Chinese patients
H. Liu, Y. Chen, L. Zhao, Y. Liu, Y. Wang, X. Tian, W. Zhang, M. Li, Y. Zhao, X. Leng, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/ixcj8a
H. Liu, Y. Chen, L. Zhao, Y. Liu, Y. Wang, X. Tian, W. Zhang, M. Li, Y. Zhao, X. Leng, X. Zeng
DOI: https://doi.org/10.55563/clinexprheumatol/ixcj8a
CER14676
2022,40,9
Pg. 1657-1665
Free to view
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with age
C. Specker, M. Aringer, G.-R. Burmester, B. Killy, M.W. Hofmann, H. Kellner, F. Moosig, H.-P. Tony, G. Fliedner
DOI: https://doi.org/10.55563/clinexprheumatol/f7ff6q
C. Specker, M. Aringer, G.-R. Burmester, B. Killy, M.W. Hofmann, H. Kellner, F. Moosig, H.-P. Tony, G. Fliedner
DOI: https://doi.org/10.55563/clinexprheumatol/f7ff6q
CER14939
2022,40,9
Pg. 1666-1673
Free to view
Outcomes after lung transplantation among Chinese patients with connective tissue disease-associated interstitial lung disease and pulmonary hypertension: a retrospective cohort study
C. Ju, Q. Lian, A. Chen, X. Xu, J. Zhang, Q. Luo, D. Huang, R. Chen, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/hld9sf
C. Ju, Q. Lian, A. Chen, X. Xu, J. Zhang, Q. Luo, D. Huang, R. Chen, J. He
DOI: https://doi.org/10.55563/clinexprheumatol/hld9sf
CER14896
2022,40,9
Pg. 1674-1680
Free to view
Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis
M. Sugawara, Y. Fujieda, A. Noguchi, S. Tanimura, Y. Shimizu, I. Nakagawa, M. Yoshimura, N. Abe, M. Kono, M. Kato, K. Oku, O. Amengual, I. Yokota, H. Takahashi, T. Atsumi
DOI: https://doi.org/10.55563/clinexprheumatol/czhc93
M. Sugawara, Y. Fujieda, A. Noguchi, S. Tanimura, Y. Shimizu, I. Nakagawa, M. Yoshimura, N. Abe, M. Kono, M. Kato, K. Oku, O. Amengual, I. Yokota, H. Takahashi, T. Atsumi
DOI: https://doi.org/10.55563/clinexprheumatol/czhc93
CER15035
2022,40,9
Pg. 1681-1685
Free to view
Efficacy of intravenous neridronate in transient osteoporosis of the hip
R. D'alessandro, P. Falsetti, E. Conticini, M. Bardelli, C. Baldi, S. Gentileschi, A. Nicosia, S.G. Al Khayyat, L. Cantarini, B. Frediani
DOI: https://doi.org/10.55563/clinexprheumatol/vzknda
R. D'alessandro, P. Falsetti, E. Conticini, M. Bardelli, C. Baldi, S. Gentileschi, A. Nicosia, S.G. Al Khayyat, L. Cantarini, B. Frediani
DOI: https://doi.org/10.55563/clinexprheumatol/vzknda
CER14944
2022,40,9
Pg. 1686-1692
An ultrasonographic insight into musculoskeletal manifestation in 100 systemic lupus erythematosus patients
I.H. Popov, C. Pamfil, M.M. Tămaș, T.N. Onea, I. Felea, A. Hălbac, N. Rednic, S. Rednic
DOI: https://doi.org/10.55563/clinexprheumatol/am4oj4
I.H. Popov, C. Pamfil, M.M. Tămaș, T.N. Onea, I. Felea, A. Hălbac, N. Rednic, S. Rednic
DOI: https://doi.org/10.55563/clinexprheumatol/am4oj4
CER15009
2022,40,9
Pg. 1693-1700
Adherence of Italian rheumatologists to the EULAR recommendations and outcomes in early rheumatoid arthritis patients after starting conventional DMARDs: Methotrexate in Italian patients wiTh Rheumatoid Arthritis (the MITRA study). A cohort study of the I
M. Fornaro, F. Benaglio, C. Montecucco, B. Raffeiner, M. Di Franco, C. Iannuccelli, P. Conigliaro, C. Lomater, M. Govoni, E. Silvagni, A. Zanetti, S. Parisi, G. Carrara, C.A. Scirè, R. Caporali, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/77i56a
M. Fornaro, F. Benaglio, C. Montecucco, B. Raffeiner, M. Di Franco, C. Iannuccelli, P. Conigliaro, C. Lomater, M. Govoni, E. Silvagni, A. Zanetti, S. Parisi, G. Carrara, C.A. Scirè, R. Caporali, F. Iannone
DOI: https://doi.org/10.55563/clinexprheumatol/77i56a
CER15104
2022,40,9
Pg. 1701-1707
Free to view
Biologic retention rate and efficacy in patients with cluster-based phenotypes of ankylosing spondylitis: data from a Korean national biologics registry
H.K. Min, H.-R. Kim, S.-H. Lee, K.Y. Kang, S.-H. Park, K. Shin, J. Kim, S.-K. Kwok
DOI: https://doi.org/10.55563/clinexprheumatol/9yfunq
H.K. Min, H.-R. Kim, S.-H. Lee, K.Y. Kang, S.-H. Park, K. Shin, J. Kim, S.-K. Kwok
DOI: https://doi.org/10.55563/clinexprheumatol/9yfunq
CER14832
2022,40,9
Pg. 1708-1717
Free to view
IL-1β, IL-10 and TNF-α polymorphisms may affect systemic lupus erythematosus risk and phenotype
E. Rzeszotarska, A. Sowinska, B. Stypinska, A. Lutkowska, A. Felis-Giemza, M. Olesinska, M. Puszczewicz, D. Majewski, P.P. Jagodzinski, E. Haładyj, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/qdgq0v
E. Rzeszotarska, A. Sowinska, B. Stypinska, A. Lutkowska, A. Felis-Giemza, M. Olesinska, M. Puszczewicz, D. Majewski, P.P. Jagodzinski, E. Haładyj, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/qdgq0v
CER14937
2022,40,9
Pg. 1718-1725
NSC1122002, a TRAF-binding domain inhibitor, inhibits collagen-induced arthritis in a mouse model
T. Pan, M.-H. Hua, N. Lv
DOI: https://doi.org/10.55563/clinexprheumatol/165lpx
T. Pan, M.-H. Hua, N. Lv
DOI: https://doi.org/10.55563/clinexprheumatol/165lpx
CER15078
2022,40,9
Pg. 1726-1732
Free to view
Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines
M. Novella-Navarro, F. Genre, B. Hernández-Breijo, S. Remuzgo-Martínez, A. Martínez-Feito, D. Peiteado, I. Monjo, M.Á. González-Gay, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/a9gskx
M. Novella-Navarro, F. Genre, B. Hernández-Breijo, S. Remuzgo-Martínez, A. Martínez-Feito, D. Peiteado, I. Monjo, M.Á. González-Gay, C. Plasencia-Rodríguez, A. Balsa
DOI: https://doi.org/10.55563/clinexprheumatol/a9gskx
CER14960
2022,40,9
Pg. 1733-1737
Attaining treat-to-target endpoints with metformin in lupus patients: a pooled analysis
F. Sun, D. Zhang, H. Wang, H. Wang, Z. Liu, S. Geng, X. Wang, T. Li, W. Wan, L. Lu, X. Teng, L. Morel, S. Ye
DOI: https://doi.org/10.55563/clinexprheumatol/7y5ku8
F. Sun, D. Zhang, H. Wang, H. Wang, Z. Liu, S. Geng, X. Wang, T. Li, W. Wan, L. Lu, X. Teng, L. Morel, S. Ye
DOI: https://doi.org/10.55563/clinexprheumatol/7y5ku8
CER15150
2022,40,9
Pg. 1738-1743
Ovarian reserve in patients with spondyloarthritis: impact of biological disease-modifying anti-rheumatic drugs on fertility status
R. Scrivo, E. Anastasi, C. Castellani, F. Conti, A. Angeloni, T. Granato
DOI: https://doi.org/10.55563/clinexprheumatol/osg0fu
R. Scrivo, E. Anastasi, C. Castellani, F. Conti, A. Angeloni, T. Granato
DOI: https://doi.org/10.55563/clinexprheumatol/osg0fu
CER14915
2022,40,9
Pg. 1744-1753
Non-adherence to methotrexate was associated with high disease activity and poor health-related outcomes during a 4-year follow-up of rheumatoid arthritis patients
J.-H. Kang, S.-E. Choi, H. Xu, D.-J. Park, J.-K. Lee, S.-S. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/ir6yds
J.-H. Kang, S.-E. Choi, H. Xu, D.-J. Park, J.-K. Lee, S.-S. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/ir6yds
CER15060
2022,40,9
Pg. 1754-1761
Free to view
Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis
I.D. Smith, N. Lu, J. Wei, Y. Zhang, H.K. Choi, M.B. Bolster
DOI: https://doi.org/10.55563/clinexprheumatol/8snr4x
I.D. Smith, N. Lu, J. Wei, Y. Zhang, H.K. Choi, M.B. Bolster
DOI: https://doi.org/10.55563/clinexprheumatol/8snr4x
CER15135
2022,40,9
Pg. 1762-1768
Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study
Y.H. Kwan, L. Tan, C.S. Tan, C. López-Medina, M. Dougados, F. Proft, V. Rios-Rodriguez, J.K. Phang, E.H. Chew, T. Østbye, J. Thumboo, W. Fong
DOI: https://doi.org/10.55563/clinexprheumatol/gqsd66
Y.H. Kwan, L. Tan, C.S. Tan, C. López-Medina, M. Dougados, F. Proft, V. Rios-Rodriguez, J.K. Phang, E.H. Chew, T. Østbye, J. Thumboo, W. Fong
DOI: https://doi.org/10.55563/clinexprheumatol/gqsd66
CER15101
2022,40,9
Pg. 1769-1778
Free to view
Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational study
S. Ntali, D. Nikolopoulos, L. Pantazi, E. Emmanouilidou, C. Papagoras, A. Fanouriakis, D. Dimopoulou, I. Kallitsakis, K. Boki, V. Dania, P.I. Sidiropoulos, D.T. Boumpas, G. Bertsias
DOI: https://doi.org/10.55563/clinexprheumatol/g4rby6
S. Ntali, D. Nikolopoulos, L. Pantazi, E. Emmanouilidou, C. Papagoras, A. Fanouriakis, D. Dimopoulou, I. Kallitsakis, K. Boki, V. Dania, P.I. Sidiropoulos, D.T. Boumpas, G. Bertsias
DOI: https://doi.org/10.55563/clinexprheumatol/g4rby6
CER14963
2022,40,9
Pg. 1779-1788
Il-34 regulates MAPKs, PI3K/Akt, JAK and NF-κB pathways and induces the expression of inflammatory factors in RA-FLS
H. Yang, Y. Luo, X. Lai
DOI: https://doi.org/10.55563/clinexprheumatol/6t1d4i
H. Yang, Y. Luo, X. Lai
DOI: https://doi.org/10.55563/clinexprheumatol/6t1d4i
Brief Paper
CER15236
2022,40,9
Pg. 1789-1792
Free to view
Impaired adrenal cortex reserve in patients with rheumatic and musculoskeletal diseases who relapse upon tapering of low glucocorticoid dose
M.P. Yavropoulou, M.G. Filippa, S. Panopoulos, E. Spanos, G. Spanos, M.G. Tektonidou, P.P. Sfikakis
DOI: https://doi.org/10.55563/clinexprheumatol/x78tko
M.P. Yavropoulou, M.G. Filippa, S. Panopoulos, E. Spanos, G. Spanos, M.G. Tektonidou, P.P. Sfikakis
DOI: https://doi.org/10.55563/clinexprheumatol/x78tko
Review
CER15182
2022,40,9
Pg. 1793-1800
Free to view
Does seasonality of the microbiota contribute to the seasonality of acute gout flare?
N. Schlesinger, L. Brunetti, I.P. Androulakis
DOI: https://doi.org/10.55563/clinexprheumatol/hdtge7
N. Schlesinger, L. Brunetti, I.P. Androulakis
DOI: https://doi.org/10.55563/clinexprheumatol/hdtge7
Paediatric Rheumatology
CER15569
2022,40,9
Pg. 1801-1807
SAMHD1 associates with inflammation and vasculitis in paediatric-onset systemic lupus erythematosus
X. Zhao, C. Li, S. Li, J. Zhang, W. Kuang, J. Deng, X. Tan, C. Li, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/4k3gau
X. Zhao, C. Li, S. Li, J. Zhang, W. Kuang, J. Deng, X. Tan, C. Li, J. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/4k3gau
Letters to the Editor
CER15350
2022,40,9
Pg. 1808
Free to view
Prevalence, clinical and serologic characteristics of systemic lupus erythematosus: multicentric study in Burkina Faso and African literature review
W.J.S. Tiendrebeogo, C. Sompougdou, F. Traoré, F. Kaboré, C. Sougué, D.-D. Ouédraogo
DOI: https://doi.org/10.55563/clinexprheumatol/5o7l63
W.J.S. Tiendrebeogo, C. Sompougdou, F. Traoré, F. Kaboré, C. Sougué, D.-D. Ouédraogo
DOI: https://doi.org/10.55563/clinexprheumatol/5o7l63
CER14942
2022,40,9
Pg. 1809-1810
Free to view
Cohort study of off-label use of low-dose IL-2 therapy for systemic autoimmune diseases
O. Al Tabaa, S. Hamroun, C. Leplay, O. Fain, D. Klatzmann, A. Mekinian
DOI: https://doi.org/10.55563/clinexprheumatol/2le8p4
O. Al Tabaa, S. Hamroun, C. Leplay, O. Fain, D. Klatzmann, A. Mekinian
DOI: https://doi.org/10.55563/clinexprheumatol/2le8p4
CER15585
2022,40,9
Pg. 1811
Free to view
The IgG4-related disease: performance of classification and diagnostic criteria in a single-centre cohort of patients
G. Costanzo, L. Puccetti, R. Capecchi, S. Bilia, I. Puxeddu, A. Tavoni, P. Migliorini
DOI: https://doi.org/10.55563/clinexprheumatol/buescc
G. Costanzo, L. Puccetti, R. Capecchi, S. Bilia, I. Puxeddu, A. Tavoni, P. Migliorini
DOI: https://doi.org/10.55563/clinexprheumatol/buescc
CER15256
2022,40,9
Pg. 1812-1813
Free to view
Antiphospholipid syndrome: the burden of inadequate anticoagulation management
K. Nassarmadji, A. Brigante, C. Larroche, P. Cacoub, N. Costedoat-Chalumeau, V. Le Guern, L. Guillevin
DOI: https://doi.org/10.55563/clinexprheumatol/gobuor
K. Nassarmadji, A. Brigante, C. Larroche, P. Cacoub, N. Costedoat-Chalumeau, V. Le Guern, L. Guillevin
DOI: https://doi.org/10.55563/clinexprheumatol/gobuor
CER15779
2022,40,9
Pg. 1814-1815
Free to view
An overlooked entity in rheumatology practice: passive transfer of anti-HBc after intravenous immunoglobulin infusion
D. Üsküdar Cansu, R. Yildirim, H. Üsküdar Teke, C. Korkmaz
DOI: https://doi.org/10.55563/clinexprheumatol/qm119v
D. Üsküdar Cansu, R. Yildirim, H. Üsküdar Teke, C. Korkmaz
DOI: https://doi.org/10.55563/clinexprheumatol/qm119v
Book review
CER16222
2022,40,9
Pg. 1816
Free to view
Ankylosing Spondylitis - Axial Spondyloarthritis (2nd ed.)
S. D'angelo
DOI: https://doi.org/10.55563/clinexprheumatol/lvvr1e
S. D'angelo
DOI: https://doi.org/10.55563/clinexprheumatol/lvvr1e
Meeting Abstracts
CER16166
2022,40,9
Pg. 1817-1910
Free to view
Thirteenth International Congress on Spondyloarthritides
F. Ciccia, W.P. Maksymowych
7-9 September 2022, Gent, Belgium
DOI: https://doi.org/10.55563/clinexprheumatol/4spc2y
F. Ciccia, W.P. Maksymowych
7-9 September 2022, Gent, Belgium
DOI: https://doi.org/10.55563/clinexprheumatol/4spc2y